Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker
about
The emerging roles of human tissue kallikreins in cancerIn silico analysis of the human kallikrein gene 6.Substrate specificity determination of mouse implantation serine proteinase and human kallikrein-related peptidase 6 by phage display.Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer.Ovarian cancer biomarkers for molecular biosensors and translational medicine.OVSCORE - a validated score to identify ovarian cancer patients not suitable for primary surgery.Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas.Human tissue kallikreins and testicular cancer.High kallikrein-related peptidase 6 in non-small cell lung cancer cells: an indicator of tumour proliferation and poor prognosis.The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer.Lymph node tissue kallikrein-related peptidase 6 mRNA: a progression marker for colorectal cancerThe kallikrein world: an update on the human tissue kallikreins.Cellular distribution of human tissue kallikreins: immunohistochemical localization.Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects.Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel.Differential N-glycosylation of kallikrein 6 derived from ovarian cancer cells or the central nervous systemKLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.Prognostic value and biological role of the kallikrein-related peptidases in human malignancies.The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6).Advancements in the use of blood tests for cancer screening in women at high risk for endometrial and breast cancer.Function and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancers.Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells.Upregulation and secretion of kallikrein-related peptidase 6 (KLK6) in gastric cancer.Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells.Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA).Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma.A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineeringSeparation of kallikrein 6 glycoprotein subpopulations in biological fluids by anion-exchange chromatography coupled to ELISA and identification by mass spectrometryCharacterization of Human Kallikreins 6 and 10 in Ascites Fluid from Ovarian Cancer PatientsHuman Kallikrein 6 Degrades Extracellular Matrix Proteins and May Enhance the Metastatic Potential of Tumour Cells
P2860
Q28290701-FBD09C58-3D8C-4292-B0BF-10FC85961DA3Q33210507-1A67A9B2-BDDC-43AD-A728-77CA16D3F412Q33382170-C8BDC6DF-654D-43D1-AA03-A65D0941C1E0Q33794911-D5D7080A-68F4-490A-8040-5B8938C0F258Q34150097-EA13621D-D181-46D1-BB52-799AE77046B9Q34582595-9038A5B5-AB39-4063-B425-E47E6F6F449EQ35032994-42A48114-99AE-4307-BB78-982C5DD4CDF2Q35129502-A325193D-D21F-449C-900F-D6868BB35443Q35893466-B74749C7-9A3D-472B-ACB9-B5713DFA4C90Q35976828-3EBF3E64-6166-4ED0-A9E2-BA6EB66E794AQ36075255-211151D6-1C7E-4A2A-92EF-7FBD219050E3Q36519354-140A08BE-DAEE-4193-BB7B-7087C2C573C4Q36519359-C1B41092-CD60-44E3-8D5B-87AD5B1FB28FQ36609685-DB55DDDD-B1EB-4450-8EAE-83BBF69CB48DQ36936018-46ECAA4B-0E73-4580-8A7A-A4C35824B8AFQ37154456-A52F8E15-17F8-446C-A4CC-923C5928B425Q37400530-013974D0-D3DC-49DB-9B43-0901DBB70F52Q37690308-B6EF0BA3-9059-4C7E-97ED-44DE3FA2E4C5Q37952006-6B2120E5-9CC9-4B10-95D8-23AF64E46BCDQ37960202-C732D39C-3695-4458-84EA-8FAC1238139AQ38184632-DDD94940-E31E-4165-882A-7DEA9F9F622EQ39080408-D1600210-500A-4D13-A0E9-417434EF4FB6Q39388749-172B1E56-5F2B-4421-A548-811B29937332Q40262739-E3E80490-76EF-4D48-8C99-6C6CF1E4B40BQ43418010-2C38BF10-C85A-450C-A44C-589150240B39Q43489162-07A568E5-7B9E-4F73-BBDB-D7A077AEEBB9Q56888917-3FEDE649-50AD-483B-889D-82C362EF77E8Q57940871-1FA840B9-DD2A-48E5-9301-9EBD67764C1EQ57941738-078EFCB1-7419-43D7-B362-C6A6A27D6089Q57942209-94708EA1-54F8-4D9B-962D-3F2328D6951E
P2860
Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Immunofluorometric quantitatio ...... avourable prognostic biomarker
@ast
Immunofluorometric quantitatio ...... avourable prognostic biomarker
@en
Immunofluorometric quantitatio ...... avourable prognostic biomarker
@nl
type
label
Immunofluorometric quantitatio ...... avourable prognostic biomarker
@ast
Immunofluorometric quantitatio ...... avourable prognostic biomarker
@en
Immunofluorometric quantitatio ...... avourable prognostic biomarker
@nl
prefLabel
Immunofluorometric quantitatio ...... avourable prognostic biomarker
@ast
Immunofluorometric quantitatio ...... avourable prognostic biomarker
@en
Immunofluorometric quantitatio ...... avourable prognostic biomarker
@nl
P2093
P2860
P3181
P356
P1476
Immunofluorometric quantitatio ...... avourable prognostic biomarker
@en
P2093
B R Hoffman
D Katsaros
E P Diamandis
G Giardina
I A Rigault de la Longrais
M Massobrio
S Fracchioli
P2860
P2888
P304
P3181
P356
10.1038/SJ.BJC.6600533
P407
P577
2002-09-23T00:00:00Z
P5875
P6179
1012197737